GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OCSE:NSIS B) » Definitions » Cyclically Adjusted PB Ratio

Novonesis (Novozymes) B (OCSE:NSIS B) Cyclically Adjusted PB Ratio : 8.12 (As of Jul. 10, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Novonesis (Novozymes) B Cyclically Adjusted PB Ratio?

As of today (2025-07-10), Novonesis (Novozymes) B's current share price is kr456.50. Novonesis (Novozymes) B's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr56.19. Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio for today is 8.12.

The historical rank and industry rank for Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio or its related term are showing as below:

OCSE:NSIS B' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.23   Med: 9.47   Max: 13.83
Current: 8.17

During the past years, Novonesis (Novozymes) B's highest Cyclically Adjusted PB Ratio was 13.83. The lowest was 6.23. And the median was 9.47.

OCSE:NSIS B's Cyclically Adjusted PB Ratio is ranked worse than
92.26% of 1228 companies
in the Chemicals industry
Industry Median: 1.645 vs OCSE:NSIS B: 8.17

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Novonesis (Novozymes) B's adjusted book value per share data for the three months ended in Mar. 2025 was kr179.682. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr56.19 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Chart

Novonesis (Novozymes) B Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.43 13.63 7.97 8.23 7.78

Novonesis (Novozymes) B Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.23 - 8.70 7.78 7.14

Competitive Comparison of Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio falls into.


;
;

Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=456.50/56.19
=8.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Novonesis (Novozymes) B's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=179.682/120.2000*120.2000
=179.682

Current CPI (Mar. 2025) = 120.2000.

Novonesis (Novozymes) B Quarterly Data

Book Value per Share CPI Adj_Book
201503 36.538 100.200 43.831
201506 36.524 100.300 43.771
201509 36.415 100.200 43.683
201512 38.177 99.800 45.981
201603 35.153 100.200 42.170
201606 36.448 100.600 43.549
201609 36.695 100.200 44.019
201612 39.455 100.300 47.283
201703 36.839 101.200 43.755
201706 36.132 101.200 42.916
201709 36.656 101.800 43.281
201712 38.403 101.300 45.568
201803 34.931 101.700 41.285
201806 36.856 102.300 43.305
201809 37.859 102.400 44.440
201812 39.691 102.100 46.727
201903 37.903 102.900 44.275
201906 38.626 102.900 45.120
201909 39.505 102.900 46.147
201912 40.753 102.900 47.605
202003 38.199 103.300 44.448
202006 38.557 103.200 44.908
202009 38.651 103.500 44.887
202012 40.205 103.400 46.737
202103 38.621 104.300 44.509
202106 39.297 105.000 44.986
202109 41.771 105.800 47.456
202112 42.674 106.600 48.118
202203 40.783 109.900 44.605
202206 43.802 113.600 46.347
202209 49.452 116.400 51.066
202212 49.949 115.900 51.802
202303 46.526 117.300 47.676
202306 48.313 116.400 49.890
202309 52.164 117.400 53.408
202312 50.410 116.700 51.922
202403 0.000 118.400 0.000
202406 176.857 118.500 179.394
202412 178.804 118.900 180.759
202503 179.682 120.200 179.682

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novonesis (Novozymes) B  (OCSE:NSIS B) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines